Eleni Karakike , Evangelos J. Giamarellos-Bourboulis Frontiers in Immunology 2019 Jan 31;10:55 DOI 10.3389/fimmu.2019.00055 View article 🡇 Funding EK is funded by the Horizon 2020 Marie Skłodowska-Curie Grant European Sepsis Academy (grant 676129 paid to the University of Athens). EG-B has received funding from the FrameWork 7 program HemoSpec and
Garyfallia Poulakou, Georgios Renieris, Labros Sabrakos, Olympia Zarkotou, Katherine Themeli-Digalaki, Efstathia Perivolioti, Eleni Kraniotaki, Evangelos J. Giamarellos-Bourboulis, Nikolaos Zavras International Journal of Antimicrobial Agents 2019 Feb;53(2):190-194 DOI: 10.1016/j.ijantimicag.2018.10.024View article 🡇 Funding This study was funded by the Hellenic Institute for the Study of Sepsis. The funding source was not involved in the study
Patrick Möhnle, Simon Hirschberger, Ludwig Christian Giuseppe Hinske, Josef Briegel, Max Hübner, Sebastien Weis, Georgios Dimopoulos, Michael Bauer, Evangelos J. Giamarellos-Bourboulis, Simone Kreth Molecular Medicine 2018 Oct 17;24(1):54 DOI: 10.1186/s10020-018-0056-zDownload pdf 🡇 Funding This work has been funded by the Charles-Evans-Foundation, New Jersey, USA. Sebastian Weis and Michael Bauer are supported by the
Ioannis Strouvalis, Christina Routsi, Maria Adamopoulou, Maria Raftogiannis, George Renieris, Stylianos E Orfanos, Anastasia Kotanidou, Labros Sabracos, Evangelos J. Giamarellos-Bourboulis Respirology 2018 Oct;23(10):942-949 DOI: 10.1111/resp.13320View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Pseudomonas; outcome; pneumonia; vascular endothelial growth factor
Completed study Official Study Title a SUPar guided doublE-blind Randomized clinical trial of Initiation Of antibiotics foR presumed infection at the emergency department Brief Description SUPERIOR is a randomized clinical trial aiming to evaluate suPAR - guided medical intervention, consisting of early antibiotic administration at the emergency room for presumed infection and sepsis and
Karolina Akinosoglou, Spyridoula Theodoraki, Theologia Gkavogianni, Aikaterini Pistiki, Evangelos J. Giamarellos-Bourboulis, Charalambos A Gogos Cytokine 2018 Oct;110:288-290 DOI: 10.1016/j.cyto.2018.01.019View article 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis. Keywords: Anti-inflammatory mediators; Pro-inflammatory mediators; SIRS; Sepsis; qSOFA
Theodora Kanni, Othmar Zenker, Maria Habel, Niels C Riedemann, Evangelos J. Giamarellos-Bourboulis British Journal of Dermatology 2018 Aug;179(2):413-419 DOI: 10.1111/bjd.16428View article 🡇 Funding This study was funded in part by InflaRx GmbH, Jena, Germany, and in part by the Hellenic Institute for the Study of Sepsis. Keywords: Hidradenitis Suppurativa; immunology; biomarkers
Christian Krautz, Sarah L Maier, Maximilian Brunner, Melanie Langheinrich, Evangelos J. Giamarellos-Bourboulis, Charalambos Gogos, Apostolos Armaganidis, Frank Kunath, Robert Grützmann, Georg F Weber Journal of Critical Care 2018 Jun;45:71-75 DOI: 10.1016/j.jcrc.2018.01.013 View article 🡇 Keywords: Circulating B cells; Plasma IgM; Sepsis; Sepsis outcome
Dimitrios Sinapidis, Vassileios Kosmas, Vasileios Vittoros, Ioannis M. Koutelidakis, Aikaterini Pantazi, Aggelos Stefos, Konstantinos E. Katsaros, Karolina Akinosoglou, Magdalini Bristianou, Konstantinos Toutouzas, Michael Chrisofos and Evangelos J. Giamarellos-Bourboulis BMC Infectious Diseases, May 2018 DOI 10.1186/s12879-018-3156-zDownload pdf 🡇 Funding The study was funded by the Hellenic Institute for the Study of Sepsis.
Theodora Kanni, Maria Argyropoulou, Themistoklis Spyridopoulos, Aikaterini Pistiki, Michael Stecher, Charles A Dinarello, John Simard, Evangelos J. Giamarellos-Bourboulis Journal of Investigative Dermatology 2018 Apr;138(4):795-801 DOI: 10.1016/j.jid.2017.10.030View article 🡇 Funding This study was supported in part by XBiotech (Austin, TX) and the Hellenic Institute for the Study of Sepsis. Keywords: Hidradenitis Suppurativa Related